PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer

Robert M. Kwee, Charles Marcus, Sara Sheikhbahaei, Rathan M. Subramaniam

Research output: Contribution to journalArticle

Abstract

PET with fluorodeoxyglucose F 18/computed tomography (18F-FDG PET/CT) has evolved into an indispensable imaging technique in the management of patients with esophageal cancer. Staging with 18F-FDG PET/CT is strongly associated with overall survival and certain 18F-FDG PET/CT parameters predict patient survival. Current evidence supporting the validity of the use of 18F-FDG PET/CT in the tumor delineation process for radiation treatment planning in patients with esophageal cancer is still limited. It is useful in determining treatment response after neoadjuvant therapy and thereby has an impact on management. 18F-FDG PET/CT plays a role in the diagnosis of recurrent disease in patients with a background of clinical suspicion.

Original languageEnglish (US)
Pages (from-to)197-205
Number of pages9
JournalPET Clinics
Volume10
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Fluorodeoxyglucose F18
Esophageal Neoplasms
tomography
cancer
Tomography
delineation
imaging techniques
planning
therapy
Neoadjuvant Therapy
tumors
Survival
radiation
Radiation
Therapeutics
Neoplasms

Keywords

  • F-Fluorodeoxyglucose
  • Computed tomography
  • Esophageal cancer
  • Management
  • Positron emission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Medicine(all)

Cite this

PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer. / Kwee, Robert M.; Marcus, Charles; Sheikhbahaei, Sara; Subramaniam, Rathan M.

In: PET Clinics, Vol. 10, No. 2, 01.04.2015, p. 197-205.

Research output: Contribution to journalArticle

Kwee, Robert M. ; Marcus, Charles ; Sheikhbahaei, Sara ; Subramaniam, Rathan M. / PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer. In: PET Clinics. 2015 ; Vol. 10, No. 2. pp. 197-205.
@article{0b60f9bec172465794380340555729f6,
title = "PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer",
abstract = "PET with fluorodeoxyglucose F 18/computed tomography (18F-FDG PET/CT) has evolved into an indispensable imaging technique in the management of patients with esophageal cancer. Staging with 18F-FDG PET/CT is strongly associated with overall survival and certain 18F-FDG PET/CT parameters predict patient survival. Current evidence supporting the validity of the use of 18F-FDG PET/CT in the tumor delineation process for radiation treatment planning in patients with esophageal cancer is still limited. It is useful in determining treatment response after neoadjuvant therapy and thereby has an impact on management. 18F-FDG PET/CT plays a role in the diagnosis of recurrent disease in patients with a background of clinical suspicion.",
keywords = "F-Fluorodeoxyglucose, Computed tomography, Esophageal cancer, Management, Positron emission tomography",
author = "Kwee, {Robert M.} and Charles Marcus and Sara Sheikhbahaei and Subramaniam, {Rathan M.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.cpet.2014.12.003",
language = "English (US)",
volume = "10",
pages = "197--205",
journal = "PET Clinics",
issn = "1556-8598",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - PET with fluorodeoxyglucose F 18/computed tomography in the clinical management and patient outcomes of esophageal cancer

AU - Kwee, Robert M.

AU - Marcus, Charles

AU - Sheikhbahaei, Sara

AU - Subramaniam, Rathan M.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - PET with fluorodeoxyglucose F 18/computed tomography (18F-FDG PET/CT) has evolved into an indispensable imaging technique in the management of patients with esophageal cancer. Staging with 18F-FDG PET/CT is strongly associated with overall survival and certain 18F-FDG PET/CT parameters predict patient survival. Current evidence supporting the validity of the use of 18F-FDG PET/CT in the tumor delineation process for radiation treatment planning in patients with esophageal cancer is still limited. It is useful in determining treatment response after neoadjuvant therapy and thereby has an impact on management. 18F-FDG PET/CT plays a role in the diagnosis of recurrent disease in patients with a background of clinical suspicion.

AB - PET with fluorodeoxyglucose F 18/computed tomography (18F-FDG PET/CT) has evolved into an indispensable imaging technique in the management of patients with esophageal cancer. Staging with 18F-FDG PET/CT is strongly associated with overall survival and certain 18F-FDG PET/CT parameters predict patient survival. Current evidence supporting the validity of the use of 18F-FDG PET/CT in the tumor delineation process for radiation treatment planning in patients with esophageal cancer is still limited. It is useful in determining treatment response after neoadjuvant therapy and thereby has an impact on management. 18F-FDG PET/CT plays a role in the diagnosis of recurrent disease in patients with a background of clinical suspicion.

KW - F-Fluorodeoxyglucose

KW - Computed tomography

KW - Esophageal cancer

KW - Management

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=84926143838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926143838&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2014.12.003

DO - 10.1016/j.cpet.2014.12.003

M3 - Article

C2 - 25829086

AN - SCOPUS:84926143838

VL - 10

SP - 197

EP - 205

JO - PET Clinics

JF - PET Clinics

SN - 1556-8598

IS - 2

ER -